Skip to main content

Table 4 Auxological and biochemical parameters of patients with available target height, bone age, and biochemical data.

From: The Auxological and Biochemical Continuum of Short Children Born Small for Gestational Age (SGA) or with Normal Birth Size (Idiopathic Short Stature)

 

Dimension

All ()

ISS ()

SGA ()

Age at T1

Years

6.07 2.45 ()

6.21 2.37 ()

5.42 2.78 ()

Age at T2 (years)

years

7.88 2.73 ()

8.06 2.65 ()

7.29 2.92 ()

Height at T1

SDS

2.83 0.69

2.72 0.54

3.32 0.94

Height at T2

SDS

2.66 0.61

2.53 0.42

3.26 0.91

Delta height gain

SDS

0.08 0.2

0.1 0.19

0.02 0.24

Target height

SDS

0.65 0.57

0.66 0.53

0.63 0.72

Ht at T2 minus THT

SDS

2.01 0.73

1.87 0.56

2.63 1.06

Below target range

( %)

85 (74.6%)

68 (73%)

17 (81.0%)

BA-CA

years

1.54 1.06

1.61 1.06

1.26 1.05

PAH

SDS

1.83 1.08 ()

1.71 1.05 ()

2.4 1.09 ()

Ht-PAH

SDS

0.71 1.01 ()

0.76 ± 1.02 ()

0.48 0.97 ()

Ht SDSPAH SDS

( %)

43 (75%)

37 (79%)

6 (60%)

PAH-THT

SDS

1.14 1.12 ()

1.01 1.18 ()

1.78 0.96 ()

PAH SDStarget range

(,%)

13 (22.8%)

9 (19.1%)

4 (40%)

IGF-I

SDS

1.21 0.82

1.29 0.82

0.85 0.73

IGF-I 2

(,%)

19 (16.7%)

18 (19.4%)

1 (4.8%)

IGFBP-3

SDS

0.19 0.94 ()

0.12 0.95 ()

0.52 0.81 ()

IGFBP-3 SDS 2

( %)

8 (7.3%)

6 (6.7%)

2 (10.5%)

  1. Mean (SD) are shown, except when indicated otherwise.
  2. T1: First prepubertal measurement
  3. T2: Timepoint of inclusion into the study
  4. Height SDS was calculated based on Prader et al. [10]
  5. Target height (TH) was calculated according to Hermanussen and Cole [11]
  6. Bone age (BA) minus chronological age (CA)
  7. Predicted adult height (PAH).